DB17290InvestigationalCell transplant therapies
CNDO-109 are CNDO-109-activated allogeneic natural killer cells.
- Also known as
- CNDO-109-AANK Cells · CNDO-109-activated allogeneic natural killer cells · CNDO-109-activated allogeneic NK cell therapy · CNDO-109-NK · CNDO-109-NK cells
- Code names
- CNDO-109
What you can answer from here — as of April 23, 2025
Which companies are running trials of CNDO-109, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account